Zobrazeno 1 - 10
of 223
pro vyhledávání: '"Marieke J H A Kruip"'
Autor:
Eva K. Kempers, Qingui Chen, Chantal Visser, Eric C. M. van Gorp, Frederikus A. Klok, Suzanne C. Cannegieter, Marieke J. H. A. Kruip
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-11 (2023)
Abstract This population-based cohort study aimed to describe changes in incidence of cardiovascular disease (CVD) hospital diagnoses during the COVID-19 pandemic in The Netherlands compared with the pre-pandemic period. We used Dutch nationwide stat
Externí odkaz:
https://doaj.org/article/c72198ff8a414ceeb4d6781dd6eebeaa
Autor:
Jetske Graafsma, Joanna E Klopotowska, Hieronymus J Derijks, Ewoudt M W van de Garde, Rien H L Hoge, Marieke J H A Kruip, Karina Meijer, Fatma Karapinar-Carkit, Patricia M L A van den Bemt
Publikováno v:
PLoS ONE, Vol 19, Iss 6, p e0306033 (2024)
Antithrombotics require careful monitoring to prevent adverse events. Safe use can be promoted through so-called antithrombotic stewardship. Clinical decision support systems (CDSSs) can be used to monitor safe use of antithrombotics, supporting anti
Externí odkaz:
https://doaj.org/article/fb72e9f2b4574e468baef9ed9a092c6d
Autor:
Romy T. Meier, Leendert Porcelijn, Suzanne Hofstede-van Egmond, Camila Caram-Deelder, Jonathan M. Coutinho, Yvonne M. C. Henskens, Marieke J. H. A. Kruip, An K. Stroobants, Jaap J. Zwaginga, C. Ellen van der Schoot, Masja de Haas, Rick Kapur
Publikováno v:
Antibodies, Vol 13, Iss 2, p 35 (2024)
Vaccine-induced thrombotic thrombocytopenia (VITT) is a rare but severe complication following COVID-19 vaccination, marked by thrombocytopenia and thrombosis. Analogous to heparin-induced thrombocytopenia (HIT), VITT shares similarities in anti-plat
Externí odkaz:
https://doaj.org/article/eae254c8916047379802a27df9b623a3
Autor:
Chantal Visser, Marieke J. H. A. Kruip, Janet Brantsma-Van der Graaf, Eric E. van Thiel, Mark-David Levin, Peter E. Westerweel
Publikováno v:
TH Open, Vol 07, Iss 03, Pp e280-e284 (2023)
Externí odkaz:
https://doaj.org/article/e19f231c29b24be8bde0cd61fdf2701b
Autor:
Matthijs P. Raadsen, Chantal Visser, A. H. Ayesha Lavell, Anita A. G. A. van de Munckhof, Jonathan M. Coutinho, Moniek P. M. de Maat, Corine H. GeurtsvanKessel, Amsterdam UMC COVID-19 S3/HCW Study Group, Marije K. Bomers, Bart L. Haagmans, Eric C. M. van Gorp, Leendert Porcelijn, Marieke J. H. A. Kruip
Publikováno v:
Vaccines, Vol 11, Iss 12, p 1851 (2023)
Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a rare autoimmune condition associated with recombinant adenovirus (rAV)-based COVID-19 vaccines. It is thought to arise from autoantibodies targeting platelet factor 4 (aPF4), triggered by
Externí odkaz:
https://doaj.org/article/bda45af9de654482bbae9389198b5821
Autor:
Tessa Noordermeer, Roger E. G. Schutgens, Chantal Visser, Emma Rademaker, Moniek P. M. deMaat, A. J. Gerard Jansen, Maarten Limper, Olaf L. Cremer, Marieke J. H. A. Kruip, Henrik Endeman, Coen Maas, Bas deLaat, Rolf T. Urbanus, the Dutch COVID & Thrombosis Coalition (DCTC)
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 6, Pp n/a-n/a (2022)
Abstract Background Thrombosis is a frequent and severe complication in patients with coronavirus disease 2019 (COVID‐19) admitted to the intensive care unit (ICU). Lupus anticoagulant (LA) is a strong acquired risk factor for thrombosis in various
Externí odkaz:
https://doaj.org/article/d2ccba33e5dc4756adb1c0418654d235
Autor:
Anne‐Fleur Zwagemaker, Fabienne R. Kloosterman, Michiel Coppens, Samantha C. Gouw, Sara Boyce, Catherine N. Bagot, Erik A. M. Beckers, Paul Brons, Giancarlo Castaman, Jeroen Eikenboom, Shannon Jackson, Marieke J. H. A. Kruip, Frank W. G. Leebeek, Karina Meijer, Laurens Nieuwenhuizen, Ingrid Pabinger, Karin Fijnvandraat, the DYNAMO Study Group
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 6, Pp n/a-n/a (2022)
Abstract Background Desmopressin is an important treatment option in nonsevere hemophilia A because it has several benefits compared with factor (F) concentrates, including no inhibitor risk and much lower costs. Despite these advantages, data are li
Externí odkaz:
https://doaj.org/article/a16e8de542a44393ab495934c494f90e
Autor:
Linda Nab, Rolf H. H. Groenwold, Frederikus A. Klok, Soerajja Bhoelan, Marieke J. H. A. Kruip, Suzanne C. Cannegieter
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 6, Pp n/a-n/a (2022)
Abstract Background Coagulation abnormalities and coagulopathy are recognized as consequences of severe acute respiratory syndrome coronavirus 2 infection and the resulting coronavirus disease 2019 (COVID‐19). Specifically, venous thromboembolism (
Externí odkaz:
https://doaj.org/article/75388a07b67e49a8b4080a8db1392560
Autor:
Jessica M. Heijdra, Ferdows Atiq, Wala Al Arashi, Quincy Kieboom, Esmee Wuijster, Karina Meijer, Marieke J. H. A. Kruip, Frank W. G. Leebeek, Marjon H. Cnossen, in collaboration with the OPTI‐CLOT Study Group
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 6, Pp n/a-n/a (2022)
Abstract Background Individuals with von Willebrand disease (VWD) require desmopressin testing because of interindividual response differences. However, testing is burdensome, while not all patients may need extensive testing. Objectives To provide v
Externí odkaz:
https://doaj.org/article/fef425826bc741c78576e14267ed4a79
Autor:
Marieke J. H. A. Kruip, Suzanne C. Cannegieter, Hugo ten Cate, Eric C. M. vanGorp, Nicole P. Juffermans, Frederikus A. Klok, Coen Maas, Anton Vonk‐Noordegraaf, Dutch & COVID Thrombosis Coalition study group
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 2, Pp 278-290 (2021)
Abstract The incidence of venous thrombosis, mostly pulmonary embolism (PE), ranging from local immunothrombosis to central emboli, but also deep vein thrombosis (DVT) in people with coronavirus disease 2019 (COVID‐19) is reported to be remarkably
Externí odkaz:
https://doaj.org/article/421c449d256c4372a8b96409b6e82d20